🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesMy A1C dropped so fast my doctor thought the lab made an error — my results so far

My A1C dropped so fast my doctor thought the lab made an error — my results so far

JakeSmashed95 Mon, Feb 19, 2024 at 5:39 PM 18 replies 2,301 viewsPage 1 of 4
This thread is more than 25 months old. Information may be outdated. Consider searching for more recent discussions.
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Feb 19, 2024 at 7:04 PM#1
Let's build a community tracker! Share your A1c journey on GLP-1 therapy. Format: - Medication & dose - Starting A1c - Current A1c - Time on medication - Type 2 or non-diabetic I'll start: Semaglutide 1.0 mg weekly | Timepoint | A1c | Notes | |-----------|-----|-------| | Baseline (Nov 2024) | 7.8% | Newly diagnosed T2D | | 3 months | 6.4% | Added metformin 500mg | | 6 months | 5.7% | Dropped metformin | | 9 months (now) | 5.4% | Diet + sema only | My endo literally said "you've achieved pharmacological remission." I cried in the office lol. No shame. 🥲
21 21Dr.PainCLE, mike_mealprep, NicoleRaleigh and 18 others
Reply Quote Save Share Report
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Feb 19, 2024 at 7:21 PM#2
Love this thread. Here's mine: Tirzepatide 10 mg weekly | Timepoint | A1c | Fasting Glucose | |-----------|-----|----------------| | Baseline (Mar 2025) | 9.2% | 186 mg/dL | | 3 months | 6.8% | 118 mg/dL | | 5 months (now) | 6.1% | 102 mg/dL | T2D diagnosed 4 years ago. Was on metformin + glipizide. Dropped glipizide at month 3, may drop metformin soon. My doctor is cautiously optimistic. The 9.2 to 6.1 in 5 months blows my mind.
20 0JakeSmashed95, NauseaFreeNow, SteveThurs and 17 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Feb 19, 2024 at 7:38 PM#3
Not as dramatic but I'm happy with my progress: Semaglutide 0.5 mg weekly (can't tolerate higher doses) | Timepoint | A1c | |-----------|-----| | Baseline | 6.9% | | 3 months | 6.5% | | 6 months | 6.2% | | 9 months | 5.9% | | 12 months | 5.8% | Slow but consistent. My doctor says the trend matters more than the speed. I'll take it.
Last edited: Feb 19, 2024 at 11:38 PM
4 21Dr.PulmRoch, maya_sedona, stefan_berlin and 1 other
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
Feb 19, 2024 at 7:55 PM#4
Okay so I'm a bit worried. I'm prediabetic (not T2D) and started Wegovy for weight loss. My A1c was 5.9% at baseline and after 4 months it's... still 5.9%. No change. My fasting glucose went from 108 to 96 though. Is the A1c supposed to drop faster? Am I a non-responder?
43 5CryptoCarl, MariaRD, AussieAnna and 40 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Feb 19, 2024 at 8:12 PM#5
> Is the A1c supposed to drop faster? Am I a non-responder? Carl, chill — you're fine 😄 A few things: 1. A1c reflects a 3-month average of blood sugar, weighted toward the most recent 30 days. At 4 months you're really only seeing ~1 month of true effect. 2. Your fasting glucose dropped 12 points — that IS working. 3. Going from 5.9% to 5.9% might mean you went from "high 5.9" to "low 5.9" — A1c resolution is only about 0.1%. 4. For prediabetics, the A1c changes are smaller in absolute terms because you're starting lower. Going from 5.9 to 5.5 is actually a bigger relative improvement than someone going from 9 to 7. Give it another 3 months. I bet you'll see 5.5-5.6% at your next draw.
34 0MikeNYC_runner and 31 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register